Skip to navigationSkip to contentSkip to footerHelp using this website - Accessibility statement
  • Vectus Biosystems Limited

    Medical Research and Development.

    VBS$0.078
     0.001 1.30%

    Data last updated:Jun 7, 2024 – 3.58pm. Data is 20 mins delayed.

    Previous Close

    0.077

    Open

    0.080

    Day Range

    0.076 - 0.080

    52 Week Range

    0.076 - 0.500

    Volume

    324,969

    Value

    25,755

    Bid

    0.078

    Ask

    0.083

    Dividend Yield

    0.00%

    P/E Ratio

    0.00

    Market Cap

    4.150M

    Total Issue

    53,210,521

    ASX Announcements

    Cleansing Notice

    Cleansing Notice

    • May 30, 2024
    • 1 page

    Application for quotation of securities - VBS

    Appendix 2A (Application for Quotation of Securities)

    • May 29, 2024
    • 6 pages

    Appointment of Interim Chief Technology Officer

    Company Administration - Other

    • May 23, 2024
    • 1 page

    Final Director's Interest Notice 3Z - KD

    Final Director’s Interest Notice

    • May 20, 2024
    • 1 page

    Market Sensitive

    Passing of Vectus CEO

    Director Appointment/Resignation, Company Administration - Other

    • May 20, 2024
    • 1 page

    View all VBS announcements

    May 2022

    Maurie Stang says 2022 is shaping up to be a turning point for Vectus Biosystems.

    Why medtech veteran Maurie Stang says the time is right for Vectus

    The share price of the ASX-listed small cap surged more than 9 per cent on Wednesday.

    • Yolanda Redrup

    Copyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.